Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

M3-DR-TB Coordinator: TB Treatment and Care

  1. Home
  3. M3-DR-TB Coordinator: TB Treatment and Care
  4. M3-DR-TB Coordinator: TB Treatment and Care

  • DR-TB Coordinator: General concepts in TB Treatment

    • Goals of treatment
    • Strategies for TB Treatment
    • Pharmacological Basis of treatment
    • Treatment Phases
    • Fixed Dose Combinations [FDC]s
    • Advantages of FDCs
    • FDCs used in NTEP
    • TB Drug Regimen
    • TB Treatment Initiation
    • Follow-up of TB patient
    • TB Treatment Outcome
    • Adverse Event Definitions and Classifications
    • Classification of Adverse Drug Events
    • Types of ADR of TB Treatment
    • Management of Adverse Drug Reactions [ADRs] of TB Treatment
    • Follow-up sputum examination
    • Long Term Post-treatment follow up of TB patients
    • TB Treatment Card
    • NTEP TB ID Card
    • PMDT Treatment Book
    • DR-TB Treatment Register
    • Transfer of TB Patient Ownership
    • Treatment Support Plan
    • Management of EPTB
    • Management of Patients with Treatment Interruptions
    • Death Audit

  • DR-TB Coordinator: TB and Comorbidities

    • TB Co-morbidities & Special Situations
    • TB in Pregnant and Lactating Women
    • Diabetes among people with TB
    • Malnutrition among people with TB
    • Alcoholism among people with TB
    • Tobacco use among people with TB
    • Silicosis in people with TB
    • Cancer in People with TB
    • COVID-19 in TB patients
    • TB Comorbidity Committee
    • District TB-comorbidity Coordination Committees [DTCC]

  • DR-TB Coordinator: DS-TB Treatment and care

    • Categorization of DSTB Treatment Regimen
    • Treatment Regimen for DSTB – Adult
    • Treatment Regimen for DSTB - Pediatrics
    • TB Treatment – Steps
    • ADRs to First Line Treatment
    • Drug-Resistant Tuberculosis [DR-TB]
    • Types of Drug Resistance Tuberculosis -DRTB
    • Goals of DR-TB Treatment
    • Newer Anti-TB Drugs
    • Weight Band-wise Dosages of DR-TB Drugs for Adults
    • Treatment of DR-TB in Children
    • DR-TB Treatment Care Cascade
    • Pre-treatment Counselling
    • Pre treatment evaluation of DRTB cases
    • DR-TB Treatment – Patient Flow
    • Second Line anti TB drugs
    • DR-TB Treatment Regimens
    • Treatment Algorithm for MDR/RR-TB
    • Management of M/XDR-TB Treatment During Pregnancy​
    • DR-TB Treatment in Pregnancy: Recommendation for the Use of Contraception​
    • Follow-up Monitoring of DR-TB Patients
    • Rehabilitation service to TB patients
    • Palliative Care approach and benefits in DR-TB
    • Need for Palliative Care in DR-TB Patients
    • Interim Treatment Outcomes of DR-TB Cases
    • Final Treatment Outcomes of DR-TB Cases
    • Interim reports of DR-TB Treatment
    • Outcome Report
    • PMDT Report

  • DR-TB Coordinator: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen

    • Shorter oral Bedaquiline-containing MDR/RR-TB regimen
    • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE]
    • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension
    • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration
    • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Dosage of Drugs for Adults
    • Possible Adverse Events Due to Drugs in Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
    • Follow-up Evaluation of Patients on Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen

  • DR-TB Coordinator: Shorter injectable containing regimen

    • Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up​

  • DR-TB Coordinator: Longer Oral M/XDR-TB Regimen

    • Longer Oral M/XDR-TB: Regimen and Duration
    • Pre-treatment Evaluation [PTE] in Longer Oral M/XDR-TB Regimen
    • Treatment Extension in Longer Oral M/XDR-TB Regimen
    • Dosages of M/XDR-TB Drugs for Adult in Longer Oral M/XDR-TB Regimen​
    • Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
    • Details of Replacement Sequence of Drugs in Longer Oral M/XDR-TB Regimen

  • DR-TB Coordinator: Isoniazid (H) Mono/Poly DR-TB Regimen

    • Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen
    • Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
    • Adverse Drug Events: H Mono/Poly DR-TB Regimen
    • Replacement Sequence in the H Mono/Poly DR-TB

  • DR-TB Coordinator: ADR Management

    • Active TB Drug Safety Monitoring [aDSM]
    • Pharmacovigilance in NTEP
    • ADRs to Second Line Treatment
    • Management of ADR: Rash, Allergy and Anaphylaxis Reaction
    • Management of DR-TB ADR: Gastritis, abdominal pain
    • Management of DR-TB ADR: Diarrhoea and/or Flatulence
    • Management of DR-TB ADR: Hepatitis
    • Management of DR-TB ADR: Giddiness
    • Management of DR-TB ADR: QT Prolongation
    • Management of DR-TB ADR: Hematological Abnormalities
    • Management of DR-TB ADR: Hypothyroidism
    • Management of DR-TB ADR: Arthralgia
    • Management of DR-TB ADR: Peripheral Neuropathy
    • Management of DR-TB ADR: Psychotic Symptoms
    • Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity]
    • Management of DR-TB ADR: Vestibular Toxicity

  • DR-TB Coordinator: TB Infection treatment and care

    • Testing for TB Infection
    • TB Preventive Therapy
    • Eligibility for TPT
    • Cascade of Care for TPT
    • Approaches for TPT implementation
    • Counselling for IGRA/TST
    • Counselling for TPT
    • Monitoring adherence to TPT
    • Preventive Treatment for Contacts of DR-TB Patients
    • Screening among Household Contacts of DR-TB Patients

User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International